Fundraising Fox

Deborah Palestrant

Investor

Partner at 5AM Ventures

Cambridge, Massachusetts

Writes $100K – $5M checks · typically $1.5M

Contact· self-published, not guessed

Experience

  1. 5AM VenturesPartner, 5AM Ventures and Executive Chair, 4:59 Initiativecurrent2018 — present
  2. 5AM VenturesPartner, Head of 4:592018 — 2022Boston, Massachusetts
  3. 4:59 NewCo, a 5AM Ventures CompanyExecutive Chaircurrent2018 — present
  4. Latigo Biotherapeutics, Inc.Board Membercurrent2020 — present
  5. Renasant BioMember Board of Directorscurrent2023 — present
  6. Nido BiosciencesMember Board of Directorscurrent2023 — present
  7. Life Science Cares BostonMember Board of Managerscurrent2023 — present
  8. New England Venture Capital AssociationMember Board of Directorscurrent2020 — present
  9. Nvelop TherapeuticsMember Board of Directors2022 — 2024
  10. Relay TherapeuticsVice President, Corporate Development & Strategy2017 — 2018Cambridge, MA
  11. Editas MedicineSenior Director, Business Development & Strategy2013 — 2017
  12. Third Rock VenturesSenior Associate2010 — 2013
  13. Blueprint MedicinesStrategic Planning and Operations2011 — 2012
  14. Novartis Institutes for Biomedical ResearchInvestigator III2010
  15. Novartis Institutes for Biomedical ResearchResearch Investigator II2007 — 2009
  16. Novartis Institutes for Biomedical ResearchResearch Investigator I2004 — 2007
  17. The Scripps Research InstitutePostdoctoral Fellow2001 — 2004
  18. Cedars-Sinai Medical Centersummer student1990 — 1993

Skills & more

Structural Biology10Biochemistry7Biophysics12Cancer Research7Chemistry6Drug Discovery22Lifesciences13Biotechnology18Cell Biology9Molecular Biology10Oncology8Cancer5
+8 morePharmaceutical IndustryProtein ChemistryX-ray crystallographyBusiness DevelopmentEntrepreneurshipVenture CapitalStart-up VenturesDrug Development

From Deborah's professional profile.

Deals · 1

Latigo BioBoard seat

via 5AM Ventures · filed Feb 2025 · $150M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at 5AM Ventures

Alex Wareham
Management Company Controller at 5AM Ventures
Andy Schwab
Managing Partner at 5AM Ventures
Aniqa Tasnim
Senior Associate at 5AM Ventures
Anna Yaeger
Chief Investment Officer and Partner at 5AM Ventures
Arthur Tzianabos
Venture Partner at 5AM Ventures
Bella Nittolo
Administrative Assistant and Office Manager at 5AM Ventures
Brian Daniels
Venture Partner at 5AM Ventures
Caroline Chamales
Senior Executive Assistant at 5AM Ventures

Network6

Andy Schwab
Managing Partner at 5AM Ventures
Brian Daniels
Venture Partner at 5AM Ventures
Desmond Padhi
Operating Partner at Westlake Village BioPartners
Jamil Beg
Partner at 5AM Ventures
John Diekman
Founding Partner at 5AM Ventures
Katie Bodner Spielberg
Principal at 5AM Ventures

Investors connected to Deborah in public investor directories — a warm-intro map.

Frequently asked questions

Who is Deborah Palestrant?
Partner, Executive Chair, 4:59 Initiative at 5AM Ventures
Where does Deborah Palestrant work?
Deborah Palestrant is Partner at 5AM Ventures.
What check size does Deborah Palestrant write?
Deborah Palestrant typically writes checks of $100K – $5M.
What boards does Deborah Palestrant sit on?
Deborah Palestrant holds tracked board seats at Latigo Bio.
Where did Deborah Palestrant go to school?
Deborah Palestrant studied at Columbia University Vagelos College of Physicians and Surgeons (PhD, Biophysics); D'Amore-McKim School of Business at Northeastern University (MBA, High-Tech Innovation); UCLA (BS, Biochemistry).

Same school

Also attended Columbia University Vagelos College of Physicians and Surgeons20

Tristan HuntPartner at Averin CapitalShreeram AradhyeInvestor at Novartis Venture FundJoseph MayerPartner at HLM Investment PartnersJoan LaRovereOperating Partner at iSelect FundCurt LaBelleVenture Partner at Adjuvant CapitalStefano BiniHealth Moonshot Impact Board at StartUp Health

+ 14 more

Also attended D'Amore-McKim School of Business at Northeastern University31

Bruce SachsInvestor at CRV (Charles River Ventures)Kerry HullChief Financial Officer & Chief Operating Officer at CincyTechNicholas AdamsManaging Partner at Differential VenturesChristian DesmarteauxDirector of Investor Relations at MPM BioImpactElaine SunInvestor at CapitalGGretchen McCareyChief Financial Officer at Castle Island Ventures

+ 25 more

Also attended UCLA625

Ben HorowitzCo-founder & General Partner at Andreessen HorowitzRon ConwayFounder of SV AngelKirsten GreenFounder and Managing Partner at Forerunner VenturesVlad TenevCo-founder & CEO of RobinhoodRyan KingCo-founder of ChimePaul FieldingFinance & Operations at General Catalyst

+ 619 more

Also attended Mount Holyoke College29

Maria CirinoInvestor at .406 VenturesKelci HoranOffice Manager and Executive Assistant at .406 VenturesKleida MartiroManaging Director at Glasswing VenturesErin HalbrechtHead of Marketing, Platform, & Operations at Sorenson VenturesArielle JacksonHead, Corporate Communications & Industry Engagement at Longwood FundNick StokerCOO, Skyview Finance Company at Skyview Ventures

+ 23 more

Shared employers

Also worked at 5AM Ventures29

Anika GuptaInvestor at GV (Google Ventures)Susan LiuInvestment Team at 8VCGisella de la RochaVice President of Legal at MPM BioImpactMira ChaurushiyaManaging Director at Westlake Village BioPartnersLucy LiuPrincipal at Longwood FundKush M ParmarManaging Partner at 5AM Ventures

+ 23 more

Also worked at Renasant Bio1

Jamil BegPartner at 5AM Ventures

Also worked at Life Science Cares Boston1

Michelle DetwilerManaging Partner, MD, PhD at BIOSPRING PARTNERS

Also worked at Relay Therapeutics11

Anneli MathesonExecutive Assistant at Prelude VenturesJulia PianSenior Associate at Atlas VentureEli CasdinChief Investment Officer and Founder at Casdin CapitalLauren DanielChief Compliance Officer and General Counsel at 5AM VenturesJakob LovenPartner at Nextech InvestAlexis BorisyOperating Chairman at Curie.Bio

+ 5 more